Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus

S. Chiba, R. Hashimoto, Satoko Takai, M. Yohda, B. Lipska, D. R. Weinberger, H. Kunugi

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Altered expression of Disrupted-In-Schizophrenia-1 (DISC1) and dysbindin (DTNBP1), susceptibility genes for schizophrenia, in schizophrenic brain has been reported; however, the possible effect of antipsychotics on the expression levels of these genes has not yet been studied. We measured the mRNA expression levels of these genes in frontal cortex and hippocampus of mice chronically treated with typical and atypical antipsychotics by a real-time quantitative RT-PCR method. We found that atypical antipsychotics, olanzapine and risperidone, in a clinically relevant dose increased DISC1 expression levels in frontal cortex, while a typical antipsychotic, haloperidol, did not. No significant effect on dysbindin expression levels was observed in either brain region. These data suggest that prior evidence of decreased expression of dysbindin in postmortem brain of schizophrenics is not likely to be a simple artifact of antemortem drug treatment. Our results also suggest a potential role of DISC1 in the therapeutic mechanisms of certain atypical antipsychotics.

Original languageEnglish
Pages (from-to)1337-1346
Number of pages10
JournalJournal of Neural Transmission
Volume113
Issue number9
DOIs
Publication statusPublished - 01-09-2006
Externally publishedYes

Fingerprint

Frontal Lobe
Antipsychotic Agents
Hippocampus
Schizophrenia
olanzapine
Brain
Gene Expression
Risperidone
Haloperidol
Artifacts
Real-Time Polymerase Chain Reaction
Messenger RNA
Pharmaceutical Preparations
Genes

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Chiba, S. ; Hashimoto, R. ; Takai, Satoko ; Yohda, M. ; Lipska, B. ; Weinberger, D. R. ; Kunugi, H. / Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. In: Journal of Neural Transmission. 2006 ; Vol. 113, No. 9. pp. 1337-1346.
@article{0c33822079c24167bb8d069ed7d1e78c,
title = "Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus",
abstract = "Altered expression of Disrupted-In-Schizophrenia-1 (DISC1) and dysbindin (DTNBP1), susceptibility genes for schizophrenia, in schizophrenic brain has been reported; however, the possible effect of antipsychotics on the expression levels of these genes has not yet been studied. We measured the mRNA expression levels of these genes in frontal cortex and hippocampus of mice chronically treated with typical and atypical antipsychotics by a real-time quantitative RT-PCR method. We found that atypical antipsychotics, olanzapine and risperidone, in a clinically relevant dose increased DISC1 expression levels in frontal cortex, while a typical antipsychotic, haloperidol, did not. No significant effect on dysbindin expression levels was observed in either brain region. These data suggest that prior evidence of decreased expression of dysbindin in postmortem brain of schizophrenics is not likely to be a simple artifact of antemortem drug treatment. Our results also suggest a potential role of DISC1 in the therapeutic mechanisms of certain atypical antipsychotics.",
author = "S. Chiba and R. Hashimoto and Satoko Takai and M. Yohda and B. Lipska and Weinberger, {D. R.} and H. Kunugi",
year = "2006",
month = "9",
day = "1",
doi = "10.1007/s00702-005-0414-1",
language = "English",
volume = "113",
pages = "1337--1346",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer Verlag",
number = "9",

}

Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. / Chiba, S.; Hashimoto, R.; Takai, Satoko; Yohda, M.; Lipska, B.; Weinberger, D. R.; Kunugi, H.

In: Journal of Neural Transmission, Vol. 113, No. 9, 01.09.2006, p. 1337-1346.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus

AU - Chiba, S.

AU - Hashimoto, R.

AU - Takai, Satoko

AU - Yohda, M.

AU - Lipska, B.

AU - Weinberger, D. R.

AU - Kunugi, H.

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Altered expression of Disrupted-In-Schizophrenia-1 (DISC1) and dysbindin (DTNBP1), susceptibility genes for schizophrenia, in schizophrenic brain has been reported; however, the possible effect of antipsychotics on the expression levels of these genes has not yet been studied. We measured the mRNA expression levels of these genes in frontal cortex and hippocampus of mice chronically treated with typical and atypical antipsychotics by a real-time quantitative RT-PCR method. We found that atypical antipsychotics, olanzapine and risperidone, in a clinically relevant dose increased DISC1 expression levels in frontal cortex, while a typical antipsychotic, haloperidol, did not. No significant effect on dysbindin expression levels was observed in either brain region. These data suggest that prior evidence of decreased expression of dysbindin in postmortem brain of schizophrenics is not likely to be a simple artifact of antemortem drug treatment. Our results also suggest a potential role of DISC1 in the therapeutic mechanisms of certain atypical antipsychotics.

AB - Altered expression of Disrupted-In-Schizophrenia-1 (DISC1) and dysbindin (DTNBP1), susceptibility genes for schizophrenia, in schizophrenic brain has been reported; however, the possible effect of antipsychotics on the expression levels of these genes has not yet been studied. We measured the mRNA expression levels of these genes in frontal cortex and hippocampus of mice chronically treated with typical and atypical antipsychotics by a real-time quantitative RT-PCR method. We found that atypical antipsychotics, olanzapine and risperidone, in a clinically relevant dose increased DISC1 expression levels in frontal cortex, while a typical antipsychotic, haloperidol, did not. No significant effect on dysbindin expression levels was observed in either brain region. These data suggest that prior evidence of decreased expression of dysbindin in postmortem brain of schizophrenics is not likely to be a simple artifact of antemortem drug treatment. Our results also suggest a potential role of DISC1 in the therapeutic mechanisms of certain atypical antipsychotics.

UR - http://www.scopus.com/inward/record.url?scp=33745599448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745599448&partnerID=8YFLogxK

U2 - 10.1007/s00702-005-0414-1

DO - 10.1007/s00702-005-0414-1

M3 - Article

VL - 113

SP - 1337

EP - 1346

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

IS - 9

ER -